Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.nejm.org › doi › fullEarly versus Later Anticoagulation for Stroke with Atrial...

   www.nejm.org › doi › full

   24 Μαΐ 2023 · Anticoagulation with direct oral anticoagulants (DOACs) reduces the risk of ischemic stroke and systemic embolism among persons with atrial fibrillation. 1 However, whether the timing...

2. www.ahajournals.org › doi › 10Anticoagulants for Acute Ischemic Stroke: Cochrane Review

   www.ahajournals.org › doi › 10

   25 Ιουλ 2022 · Treatment with anticoagulants reduces recurrent stroke, deep vein thrombosis, and pulmonary embolism but increases bleeding risk. Data do not support the routine use of any of the currently available anticoagulants for AIS.

3. Κυριότερες Ειδήσεις

   • BMJ

     Anticoagulants after acute ischaemic stroke … and other research

     Tom Nolan reviews this week’s research Trials of direct oral anticoagulants for atrial fibrillation have excluded patients with acute ischaemic stroke because of concerns over the risk of haemorrhagic transformation of the acute infarct.

     6 ημέρες Πριν από

   • 

     Medical Xpress on MSN.com

     Stroke patients could benefit from earlier blood thinning treatment, finds research

     1 εβδομάδα Πριν από

   • 

     BMJ

     Should patients treated with direct oral anticoagulants receive intravenous thrombolytics for acute ischaemic stroke?

     2 εβδομάδες Πριν από

   • GlobalData on MSN.com

     AF stroke patients could benefit from earlier anticoagulant administration

     2 εβδομάδες Πριν από

   • The Lancet

     Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation

     2 εβδομάδες Πριν από

4. www.ahajournals.org › doi › 10Advances in Recurrent Stroke Prevention: Focus on Antithrombotic...

   www.ahajournals.org › doi › 10

   14 Απρ 2022 · The past decade has seen significant advances in stroke prevention. These advances include new antithrombotic agents, new options for dyslipidemia treatment, and novel techniques for surgical stroke prevention.

5. academic.oup.com › ehjcvp › articleNew oral anticoagulants: a practical guide for physicians

   academic.oup.com › ehjcvp › article

   • Αποθηκευμένο αντίγραφο

   25 Φεβ 2015 · New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Unlike VKAs, these anticoagulants do not require routine INR monitoring and possess favorable pharmacological properties.

6. www.ahajournals.org › doi › 10Pivotal Trials Testing the Efficacy of Novel Anticoagulants for...

   www.ahajournals.org › doi › 10

   28 Μαΐ 2024 · Atrial fibrillation (AF) increases the risk of ischemic stroke, accounts for about one quarter of all ischemic strokes worldwide, and is associated with a substantial morbidity and mortality. 1 Oral anticoagulation can reduce the stroke risk in nonvalvular AF by two thirds by using vitamin K antagonists or non‐vitamin K‐dependent oral anticoagul...

7. pubmed.ncbi.nlm.nih.gov › 34676532Anticoagulants for acute ischaemic stroke - PubMed

   pubmed.ncbi.nlm.nih.gov › 34676532

   22 Οκτ 2021 · Anticoagulants tested were standard unfractionated heparin, low-molecular-weight heparins, heparinoids, oral anticoagulants, and thrombin inhibitors. Over 90% of the evidence is related to effects of anticoagulant therapy initiated within the first 48 hours of onset.

8. www.thelancet.com › journals › lancetOptimal timing of anticoagulation after acute ischaemic stroke...

   www.thelancet.com › journals › lancet

   24 Οκτ 2024 · Early DOAC initiation within 4 days after ischaemic stroke associated with atrial fibrillation was non-inferior to delayed initiation for the composite outcome of ischaemic stroke, intracranial haemorrhage, unclassifiable stroke, or systemic embolism at 90 days. Our findings do not support the current common and guideline-supported practice of delaying DOAC initiation after ischaemic stroke ...